Annual Shareholders Equity
$3.15 B
+$102.14 M+3.36%
31 December 2023
Summary:
Exact Sciences annual stockholders equity is currently $3.15 billion, with the most recent change of +$102.14 million (+3.36%) on 31 December 2023. During the last 3 years, it has risen by +$909.75 million (+40.69%). EXAS annual shareholders equity is now -7.15% below its all-time high of $3.39 billion, reached on 31 December 2021.EXAS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$3.21 B
+$18.15 M+0.57%
30 September 2024
Summary:
Exact Sciences quarterly stockholders equity is currently $3.21 billion, with the most recent change of +$18.15 million (+0.57%) on 30 September 2024. Over the past year, it has increased by +$89.28 million (+2.86%). EXAS quarterly shareholders equity is now -12.02% below its all-time high of $3.65 billion, reached on 31 March 2021.EXAS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EXAS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.4% | +2.9% |
| 3 y3 years | +40.7% | -7.2% |
| 5 y5 years | +361.9% | +329.1% |
EXAS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.2% | +40.7% | -7.2% | +5.5% |
| 5 y | 5 years | -7.2% | +361.9% | -12.0% | +329.1% |
| alltime | all time | -7.2% | >+9999.0% | -12.0% | >+9999.0% |
Exact Sciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.21 B(+0.6%) |
| June 2024 | - | $3.19 B(+1.9%) |
| Mar 2024 | - | $3.13 B(-0.4%) |
| Dec 2023 | $3.15 B(+3.4%) | $3.15 B(+0.8%) |
| Sept 2023 | - | $3.12 B(+2.1%) |
| June 2023 | - | $3.06 B(-0.0%) |
| Mar 2023 | - | $3.06 B(+0.5%) |
| Dec 2022 | $3.04 B(-10.2%) | $3.04 B(-2.1%) |
| Sept 2022 | - | $3.11 B(-3.1%) |
| June 2022 | - | $3.21 B(-1.5%) |
| Mar 2022 | - | $3.26 B(-3.8%) |
| Dec 2021 | $3.39 B(+51.5%) | $3.39 B(-2.0%) |
| Sept 2021 | - | $3.46 B(-2.9%) |
| June 2021 | - | $3.56 B(-2.5%) |
| Mar 2021 | - | $3.65 B(+63.2%) |
| Dec 2020 | $2.24 B(-2.3%) | $2.24 B(-4.3%) |
| Sept 2020 | - | $2.34 B(-6.9%) |
| June 2020 | - | $2.51 B(-1.0%) |
| Mar 2020 | - | $2.54 B(+10.9%) |
| Dec 2019 | $2.29 B(+236.0%) | $2.29 B(+205.8%) |
| Sept 2019 | - | $748.28 M(-2.3%) |
| June 2019 | - | $765.53 M(-1.5%) |
| Mar 2019 | - | $776.94 M(+14.1%) |
| Dec 2018 | $680.94 M(+30.8%) | $680.94 M(-5.0%) |
| Sept 2018 | - | $716.73 M(-3.7%) |
| June 2018 | - | $744.39 M(+8.4%) |
| Mar 2018 | - | $687.02 M(+32.0%) |
| Dec 2017 | $520.42 M(+55.2%) | $520.42 M(-1.3%) |
| Sept 2017 | - | $527.14 M(-2.5%) |
| June 2017 | - | $540.69 M(+74.7%) |
| Mar 2017 | - | $309.52 M(-7.7%) |
| Dec 2016 | $335.30 M(+2.6%) | $335.30 M(-7.5%) |
| Sept 2016 | - | $362.33 M(+45.3%) |
| June 2016 | - | $249.39 M(-13.5%) |
| Mar 2016 | - | $288.33 M(-11.8%) |
| Dec 2015 | $326.86 M(+13.1%) | $326.86 M(-9.5%) |
| Sept 2015 | - | $361.29 M(+60.7%) |
| June 2015 | - | $224.84 M(-12.9%) |
| Mar 2015 | - | $258.21 M(-10.6%) |
| Dec 2014 | $288.98 M(+113.6%) | $288.98 M(+34.3%) |
| Sept 2014 | - | $215.10 M(-11.4%) |
| June 2014 | - | $242.87 M(+99.5%) |
| Mar 2014 | - | $121.76 M(-10.0%) |
| Dec 2013 | $135.32 M(+37.2%) | $135.32 M(-6.7%) |
| Sept 2013 | - | $145.09 M(-5.5%) |
| June 2013 | - | $153.58 M(+72.3%) |
| Mar 2013 | - | $89.13 M(-9.6%) |
| Dec 2012 | $98.59 M | $98.59 M(-10.9%) |
| Sept 2012 | - | $110.66 M(+72.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $64.02 M(-15.6%) |
| Mar 2012 | - | $75.86 M(-9.1%) |
| Dec 2011 | $83.50 M(+4.7%) | $83.50 M(+29.3%) |
| Sept 2011 | - | $64.59 M(-8.9%) |
| June 2011 | - | $70.89 M(-7.1%) |
| Mar 2011 | - | $76.28 M(-4.4%) |
| Dec 2010 | $79.75 M(+1208.7%) | $79.75 M(+348.0%) |
| Sept 2010 | - | $17.80 M(-13.3%) |
| June 2010 | - | $20.54 M(+333.5%) |
| Mar 2010 | - | $4.74 M(-22.3%) |
| Dec 2009 | $6.09 M(-350.5%) | $6.09 M(-15.9%) |
| Sept 2009 | - | $7.25 M(+4.0%) |
| June 2009 | - | $6.97 M(-709.1%) |
| Mar 2009 | - | -$1.14 M(-53.0%) |
| Dec 2008 | -$2.43 M(-138.7%) | -$2.43 M(+379.9%) |
| Sept 2008 | - | -$507.00 K(-122.6%) |
| June 2008 | - | $2.24 M(-44.5%) |
| Mar 2008 | - | $4.04 M(-35.7%) |
| Dec 2007 | $6.29 M(-58.0%) | $6.29 M(-35.5%) |
| Sept 2007 | - | $9.75 M(-22.4%) |
| June 2007 | - | $12.55 M(-7.5%) |
| Mar 2007 | - | $13.57 M(-9.3%) |
| Dec 2006 | $14.96 M(-39.2%) | $14.96 M(-11.2%) |
| Sept 2006 | - | $16.85 M(-11.3%) |
| June 2006 | - | $18.99 M(-11.8%) |
| Mar 2006 | - | $21.54 M(-12.5%) |
| Dec 2005 | $24.62 M(-35.2%) | $24.62 M(-9.7%) |
| Sept 2005 | - | $27.26 M(-10.8%) |
| June 2005 | - | $30.55 M(-9.5%) |
| Mar 2005 | - | $33.75 M(-11.1%) |
| Dec 2004 | $37.98 M(+210.6%) | $37.98 M(-10.5%) |
| Sept 2004 | - | $42.43 M(-8.8%) |
| June 2004 | - | $46.50 M(-8.0%) |
| Mar 2004 | - | $50.56 M(+313.4%) |
| Dec 2003 | $12.23 M(-68.1%) | $12.23 M(-31.4%) |
| Sept 2003 | - | $17.82 M(-24.5%) |
| June 2003 | - | $23.59 M(-23.9%) |
| Mar 2003 | - | $30.99 M(-19.2%) |
| Dec 2002 | $38.35 M(-35.0%) | $38.35 M(-14.5%) |
| Sept 2002 | - | $44.83 M(-12.8%) |
| June 2002 | - | $51.44 M(-1.5%) |
| Mar 2002 | - | $52.20 M(-11.5%) |
| Dec 2001 | $58.97 M(+112.9%) | $58.97 M(-8.6%) |
| Sept 2001 | - | $64.54 M(-6.8%) |
| June 2001 | - | $69.26 M(-6.5%) |
| Mar 2001 | - | $74.07 M |
| Dec 2000 | $27.70 M(+528.1%) | - |
| Dec 1999 | $4.41 M(-52.6%) | - |
| Dec 1998 | $9.30 M | - |
FAQ
- What is Exact Sciences annual stockholders equity?
- What is the all time high annual shareholders equity for Exact Sciences?
- What is Exact Sciences annual shareholders equity year-on-year change?
- What is Exact Sciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Exact Sciences?
- What is Exact Sciences quarterly shareholders equity year-on-year change?
What is Exact Sciences annual stockholders equity?
The current annual shareholders equity of EXAS is $3.15 B
What is the all time high annual shareholders equity for Exact Sciences?
Exact Sciences all-time high annual stockholders equity is $3.39 B
What is Exact Sciences annual shareholders equity year-on-year change?
Over the past year, EXAS annual stockholders equity has changed by +$102.14 M (+3.36%)
What is Exact Sciences quarterly stockholders equity?
The current quarterly shareholders equity of EXAS is $3.21 B
What is the all time high quarterly shareholders equity for Exact Sciences?
Exact Sciences all-time high quarterly stockholders equity is $3.65 B
What is Exact Sciences quarterly shareholders equity year-on-year change?
Over the past year, EXAS quarterly stockholders equity has changed by +$89.28 M (+2.86%)